5 Key Takeaways
-
1
Geographic atrophy (GA) does not cause total blindness, but it can significantly impair central vision and daily functioning.
-
2
All forms of age-related macular degeneration (AMD) are detrimental; both dry and wet AMD can lead to severe vision loss.
-
3
GA progression is generally faster than previously believed, with an average of 2.5 years from diagnosis to central vision loss.
-
4
Recent FDA approvals for GA treatments, such as pegcetacoplan and avacincaptad pegol, can slow disease progression.
-
5
Eye care providers must address visual impairments and refer patients to low vision specialists to enhance quality of life.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


